MRG003
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for MRG003, covering 2021-04-09 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer [Phase 1, Phase 2]